Controlling α-globin: A review of α-globin expression and its impact on β-thalassemia

Haematologica

Volumn 93, Issue 12, 2008, Pages 1868-1876

  Voon, Hsiao Phin Joanna ^a   Vadolas, Jim ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

globin; Hemoglobin; Thalassemia

Indexed keywords

ALPHA GLOBIN; MESSENGER RNA;

BETA THALASSEMIA; GENE LOCUS; GENE MUTATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN STABILITY; REVIEW;

ALPHA-GLOBINS; ANIMALS; BETA-THALASSEMIA; HEMOGLOBINS; HUMANS; PROTEIN STABILITY; TRANSCRIPTION, GENETIC;

EID: 57349129112     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.13490     Document Type: Review

References (90)

1. Higgs DR, Vickers MA, Wilkie AO, Pretorius IM, Jarman AP, Weatherall DJ. A review of the molecular genetics of the human α-globin gene cluster. Blood 1989;73:1081-104.
2. th Edition. London: Blackwell Science, 2001.
3. Schrier SL. Thalassemia: pathophysiology of red cell changes. Annu Rev Med 1994;45:211-8.
4. Goh SH, Lee YT, Bhanu NV, Cam MC, Desper R, Martin BM, et al. A newly discovered human α-globin gene. Blood 2005;106:1466-72.
5. Liebhaber SA, Russell JE. Expression and developmental control of the human α-globin gene cluster. Ann of N Y Acad Sci USA 1998;850:54-63.
6. Liebhaber SA, Wang Z, Cash FE, Monks B, Russell JE. Developmental silencing of the embryonic zeta-globin gene: concerted action of promoter and 3′ flanking region combined with stage-specific silencing by the transcribed segment. Mol Cell Biol 1996;16:2637-46.
7. Russell JE, Morales J, Makeyev AV, Liebhaber SA. Sequence divergence in the 3′ untranslated regions of human ζ- and α-globin mRNAs mediates a difference in their stabilities and contributes to efficient α-to-ζ gene development switching. Mol Cell Biol 1998;18:2173-83.
8. Liebhaber SA, Cash FE, Ballas SK. Human α-globin gene expression. The dominant role of the α 2-locus in mRNA and protein synthesis. J Biol Chem 1986;261:15327-33.
9. Albitar M, Cash FE, Peschle C, Liebhaber SA. Developmental switch in the relative expression of the α1- and α2-globin genes in humans and in transgenic mice. Blood 1992;79: 2471-4.
10. He Z, Russell JE. Antisickling effects of an endogenous human α-like globin. Nat Med 2004;10:365-7.
11. Hughes JR, Cheng JF, Ventress N, Prabhakar S, Clark K, Anguita E, et al. Annotation of cis-regulatory elements by identification, subclassification, and functional assessment of multispecies conserved sequences. Proc Natl Acad Sci USA 2005;102:9830-5.
12. Tufarelli C, Hardison R, Miller W, Hughes J, Clark K, Ventress N, et al. Comparative analysis of the α-like globin clusters in mouse, rat, and human chromosomes indicates a mechanism underlying breaks in conserved synteny. Genome Res 2004;14:623-30.
13. De Gobbi M, Anguita E, Hughes J, Sloane-Stanley JA, Sharpe JA, Koch CM, et al. Tissue-specific histone modification and transcription factor binding in {α} globin gene expression. Blood 2007;110:4503-10.
14. Flint J, Tufarelli C, Peden J, Clark K, Daniels RJ, Hardison R, et al. Comparative genome analysis delimits a chromosomal domain and identifies key regulatory elements in the α globin cluster. Hum Mol Genet 2001;10:371-82.
15. Sharpe JA, Summerhill RJ, Vyas P, Gourdon G, Higgs DR, Wood WG. Role of upstream DNase I hypersensitive sites in the regulation of human α globin gene expression. Blood 1993;82:1666-71.
16. Higgs DR, Wood WG, Jarman AP, Sharpe J, Lida J, Pretorius IM, et al. A major positive regulatory region located far upstream of the human α-globin gene locus. Genes Dev 1990; 4: 1588-601.
17. Higgs DR, Sharpe JA, Wood WG. Understanding a globin gene expression: a step towards effective gene therapy. Semin Hematol 1998;35:93-104.
18. Sharpe JA, Chan-Thomas PS, Lida J, Ayyub H, Wood WG, Higgs DR. Analysis of the human α globin upstream regulatory element (HS-40) in transgenic mice. EMBO J 1992;11:4565-72.
19. Viprakasit V, Harteveld CL, Ayyub H, Stanley JS, Giordano PC, Wood WG, et al. A novel deletion causing α thalassemia clarifies the importance of the major human α globin regulatory element. Blood 2006;107:3811-2.
20. Higgs DR, Garrick D, Anguita E, De Gobbi M, Hughes J, Muers M, et al. Understanding α-globin gene regulation: aiming to improve the management of thalassemia. Ann N Y Acad Sci USA 2005;1054:92-102.
21. Tang XB, Feng DX, Di LJ, Huang Y, Fu XH, Liu G, et al. HS-48 alone has no enhancement role on the expression of human α-globin gene cluster. Blood Cells Mol Dis 2007;38:32-6.
22. Anguita E, Sharpe JA, Sloane-Stanley JA, Tufarelli C, Higgs DR, Wood WG. Deletion of the mouse α-globin regulatory element (HS-26) has an unexpectedly mild phenotype. Blood 2002;100:3450-6.
23. Vernimmen D, De Gobbi M, Sloane-Stanley JA, Wood WG, Higgs DR. Long-range chromosomal interactions regulate the timing of the transition between poised and active gene expression. EMBO J 2007;26:2041-51.
24. Anguita E, Hughes J, Heyworth C, Blobel GA, Wood WG, Higgs DR. Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2. EMBO J 2004;23:2841-52.
25. Waggoner SA, Liebhaber SA. Regulation of α-globin mRNA stability. Exp Biol Med 2003;228:387-95.
26. Aviv H, Voloch Z, Bastos R, Levy S. Biosynthesis and stability of globin mRNA in cultured erythroleukemic Friend cells. Cell 1976;8:495-503.
27. Clegg JB, Weatherall DJ, Milner PF. Haemoglobin Constant Spring: a chain termination mutant? Nature 1971;234:337-40.
28. Morales J, Russell JE, Liebhaber SA. Destabilization of human α-globin mRNA by translation anti-termination is controlled during erythroid differentiation and is paralleled by phased shortening of the poly(A) tail. J Biol Chem 1997;272:6607-13.
29. Kiledjian M, Wang X, Liebhaber SA. Identification of two KH domain proteins in the α-globin mRNP stability complex. EMBO J 1995;14:4357-64.
30. Weiss IM, Liebhaber SA. Erythroid cell-specific mRNA stability elements in the α 2-globin 3′ nontranslated region. Mol Cell Biol 1995;15:2457-65.
31. Wang X, Kiledjian M, Weiss IM, Liebhaber SA. Detection and characterization of a 3′ untranslated region ribonucleoprotein complex associated with human α-lobin mRNA stability. Mol Cell Biol 1995;15:1769-77.
32. Weiss IM, Liebhaber SA. Erythroid cell-specific determinants of α-globin mRNA stability. Mol Cell Biol 1994;14:8123-32.
33. Ji X, Kong J, Liebhaber SA. In vivo association of the stability control protein αCP with actively translating mRNAs. Mol Cell Biol 2003;23:899-907.
34. Kong J, Liebhaber SA. A cell type-restricted mRNA surveillance pathway triggered by ribosome extension into the 3′ untranslated region. Nat Struct Mol Biol 2007;14:670-6.
35. Schrier SL, Bunyaratvej A, Khuhapinant A, Fucharoen S, Aljurf M, Snyder LM, et al. The unusual pathobiology of hemoglobin constant spring red blood cells. Blood 1997;89:1762-9.
36. Liu H, Kiledjian M. An erythroid-enriched endoribonuclease (ErEN) involved in α-globin mRNA turnover. Protein Pept Lett 2007;14:131-6.
37. Ji X, Kong J, Carstens RP, Liebhaber SA. The 3′ untranslated region complex involved in stabilization of human α-globin mRNA assembles in the nucleus and serves an independent role as a splice enhancer. Mol Cell Biol 2007;27:3290-302.
38. Komar AA, Kommer A, Krasheninnikov IA, Spirin AS. Cotranslational folding of globin. J Biol Chem 1997;272:10646-51.
39. Adachi K, Zhao Y, Surrey S. Effects of heme addition on formation of stable human globin chains and hemoglobin subunit assembly in a cell-free system. Arch Biochem Biophys 2003;413:99-106.
40. Adachi K, Zhao Y, Surrey S. Assembly of human hemoglobin (Hb) β- and γ-globin chains expressed in a cell-free system with α-globin chains to form Hb A and Hb F. J Biol Chem 2002;277:13415-20.
41. Shaeffer JR. Structure and synthesis of the unstable hemoglobin Sabin (α 2 β 2-91 Leu leads to pro). J Biol Chem 1973;248:7473-80.
42. Bargellesi A, Pontremoli S, Menini C, Conconi F. Kinetic evidence for the existence of α-globin pool in β-thalassemic reticulocytes. Eur J Biochem 1968;7:73-7.
43. Gill FM, Schwartz E. Free α-globin pool in human bone marrow. J Clin Invest 1973;52:3057-63.
44. Kihm AJ, Kong Y, Hong W, Russell JE, Rouda S, Adachi K, et al. An abundant erythroid protein that stabilizes free α-haemoglobin. Nature 2002;417:758-63.
45. Feng L, Gell DA, Zhou S, Gu L, Kong Y, Li J, et al. Molecular mechanism of AHSP-mediated stabilization of α-hemoglobin. Cell 2004; 119:629-40.
46. Zhou S, Olson JS, Fabian M, Weiss MJ, Gow AJ. Biochemical fates of α hemoglobin bound to α hemoglobin-stabilizing protein AHSP. J Biol Chem 2006; 281:32611-8.
47. Feng L, Zhou S, Gu L, Gell DA, Mackay JP, Weiss MJ, et al. Structure of oxidized α-haemoglobin bound to AHSP reveals a protective mechanism for haem. Nature 2005;435:697-701.
48. Weiss MJ, Zhou S, Feng L, Gell DA, Mackay JP, Shi Y, et al. Role of α-hemoglobin-stabilizing protein in normal erythropoiesis and β-thalassemia. Ann N Y Acad Sci 2005;1054:103-17.
49. Yu X, Kong Y, Dore LC, Abdulmalik O, Katein AM, Zhou S, et al. An erythroid chaperone that facilitates folding of α-globin subunits for hemoglobin synthesis. J Clin Invest 2007;117:1856-65.
50. Kong Y, Zhou S, Kihm AJ, Katein AM, Yu X, Gell DA, et al. Loss of α-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates β-thalassemia. J Clin Invest 2004;114:1457-66.
51. Viprakasit V, Tanphaichitr VS, Pung-Amritt P, Petrarat S, Suwantol L, Fishcer C, et al. Clinical phenotypes and molecular characterization of Hb H-Pakse disease. Haematologica 2002;87:117-25.
52. Turbpaiboon C, Limjindaporn T, Wongwiwat W, U-Pratya Y, Siritanaratkul N, Yenchitsomanus PT, et al. Impaired interaction of α-haemoglobin- stabilising protein with α-globin termination mutant in a yeast two-hybrid system. Br J Haematol 2006;-132:370-3.
53. Turbpaiboon C, Siritantikorn A, Thongnoppakhun W, Bundiworapoom D, Limwongse C, Yenchitsomanus PT, et al. Hemoglobin Pakse: presence on red blood cell membrane and detection by polymerase chain reaction-single-strand conformational polymorphism. Int J Hematol 2004;80:136-9.
54. Viprakasit V, Tanphaichitr VS, Chinchang W, Sangkla P, Weiss MJ, Higgs DR. Evaluation of α hemoglobin stabilizing protein (AHSP) as a genetic modifier in patients with β thalassemia. Blood 2004;103:3296-9.
55. Lai MI, Jiang J, Silver N, Best S, Menzel S, Mijovic A, et al. α-haemoglobin stabilising protein is a quantitative trait gene that modifies the phenotype of β-thalassaemia. Br J Haematol 2006;133:675-82.
56. Dos Santos CO, Zhou S, Secolin R, Wang X, Cunha AF, Higgs DR, et al. Population analysis of the α hemoglobin stabilizing protein (AHSP) gene identifies sequence variants that alter expression and function. Am J Hematol 2008;83:103-8.
57. Galanello P, Perseu L, Giagu N, Sole G. AHSP expression in β-thalassemia carriers with thalassemia intermedia phenotype. Blood 2003;102:[abstract 1881].
58. Thein SL. Pathophysiology of {β} thalassemia: a guide to molecular therapies. Hematology (Am Soc Hematol Educ Program). 2005:31-7.
59. Kulozik AE, Kohne E, Kleihauer E. Thalassemia intermedia: compound heterozygous β0/β(+)-thalassemia and co-inherited heterozygous α(+)-thalassemia. Ann Hematol 1993; 66: 51-4.
60. Al Qaddoumi AA. Co-inheritance of α and β-thalassemia in a Jordanian family. Clin Lab Sci 2006;19:165-8.
61. Voon HP, Wardan H, Vadolas J. Coinheritance of α- and β-thalassaemia in mice ameliorates thalassaemic phenotype. Blood Cells Mol Dis 2007;39: 184-8.
62. Steinberg MH. The interactions of α-thalassemia with hemoglobinopathies. Hematol Oncol Clin North Am 1991;5:453-73.
63. Rund D, Rachmilewitz E. Pathophysiology of α- and β-thalassemia: therapeutic implications. Semin Hematol 2001;38:343-9.
64. Sorensen S, Rubin E, Polster H, Mohandas N, Schrier S. The role of membrane skeletal-associated α-globin in the pathophysiology of β-thalassemia. Blood 1990;75:1333-6.
65. Schrier SL. Pathophysiology of the thalassemias. The Albion Walter Hewlett Award presentation. West J Med 1997;167:82-9.
66. Nagababu E, Fabry ME, Nagel RL, Rifkind JM. Heme degradation and oxidative stress in murine models for hemoglobinopathies: thalassemia, sickle cell disease and hemoglobin C disease. Blood Cell Mol Dis 2008;41:60-6.
67. Nagababu E, Rifkind JM. Heme degradation by reactive oxygen species. Antioxidants Redox Signal 2004;6:967-78.
68. Shinar E, Rachmilewitz EA. Oxidative denaturation of red blood cells in thalassemia. Semin Hematol 1990;27:70-82.
69. Advani R, Rubin E, Mohandas N, Schrier SL. Oxidative red blood cell membrane injury in the pathophysiology of severe mouse β-thalassemia. Blood 1992;79:1064-7.
70. Yuan J, Rubin E, Aljurf M, Ma L, Schrier SL. Defective assembly of membrane proteins in erythroid precursors of β-thalassemic mice. Blood 1994;84:632-7.
71. Schrier SL, Centis F, Verneris M, Ma L, Angelucci E. The role of oxidant injury in the pathophysiology of human thalassemias. Redox Rep 2003;8:241-5.
72. Lutz HU, Fasler S, Stammler P, Bussolino F, Arese P. Naturally occurring anti-band 3 antibodies and complement in phagocytosis of oxidatively-stressed and in clearance of senescent red cells. Blood Cells 1988;14:175-203.
73. Turrini F, Arese P, Yuan J, Low PS. Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition, and phagocytosis. J Biol Chem 1991;266:23611-7.
74. Fucharoen S, Winichagoon P, Thonglairuam V, Wasi P. EF Bart's disease: interaction of the abnormal α- and β-globin genes. Eur J Haematol 1988; 40:75-8.
75. Cao A, Rosatelli C, Pirastu M, Galanello R. Thalassemias in Sardinia: molecular pathology, phenotype-genotype correlation, and prevention. Am J Pediatr Hematol Oncol 1991;13:179-88.
76. Sanchaisuriya K, Fucharoen G, Saeung N, Sae-ue N, Baisungneon R, Jetsrisuparb A, et al. Molecular and hematological characterization of HbE heterozygote with α-thalassemia determinant. Southeast Asian J Trop Med Public Health 1997;28(Suppl 3):100-3.
77. Wong WS, Chan AY, Yip SF, Ma ES. Thalassemia intermedia due to coinheritance of β0/β(+)-thalassemia and (-SEA) α-thalassemia/Hb Westmead [α122(H5)His > Gln (α2)] in a Chinese family. Hemoglobin 2004;28:151-6.
78. Fucharoen G, Trithipsombat J, Sirithawee S, Yamsri S, Changtrakul Y, Sanchaisuriya K, et al. Molecular and hematological profiles of hemoglobin EE disease with different forms of α-thalassemia. Ann Hematol 2006;85:450-4.
79. Kanavakis E, Traeger-Synodinos J, Lafioniatis S, Lazaropoulou C, Liakopoulou T, Paleologos G, et al. A rare example that coinheritance of a severe form of β-thalassemia and α-thalassemia interact in a "synergistic" manner to balance the phenotype of classic thalassemic syndromes. Blood Cell Mol Dis 2004;32:319-24.
80. Wang C, Amato D. Chronic and severe haemolytic anaemia caused by co-inheritance of β-thalassaemia and triplicated α-globin genes. Br J Haematol 2007;137:489.
81. Premawardhena A, Fisher CA, Olivieri NF, de Silva S, Sloane-Stanley J, Wood WG, et al. A novel molecular basis for β thalassemia intermedia poses new questions about its pathophysiology. Blood 2005;106:3251-5.
82. Camaschella C, Kattamis AC, Petroni D, Roetto A, Sivera P, Sbaiz L, et al. Different hematological phenotypes caused by the interaction of triplicated α-globin genes and heterozygous β-thalassemia. Am J Hematol 1997;55:83-8.
83. Traeger-Synodinos J, Kanavakis E, Vrettou C, Maragoudaki E, Michael T, Metaxotou-Mavromati A, et al. The triplicated α-globin gene locus in β-thalassaemia heterozygotes: clinical, haematological, biosynthetic and molecular studies. Br J Haematol 1996;95:467-71.
84. Oron V, Filon D, Oppenheim A, Rund D. Severe thalassaemia intermedia caused by interaction of homozygosity for α-globin gene triplication with heterozygosity for β0-thalassaemia. Br J Haematol 1994;86:377-9.
85. Garewal G, Fearon CW, Warren TC, Marwaha N, Marwaha RK, Mahadik C, et al. The molecular basis of β thalassaemia in Punjabi and Maharashtran Indians includes a multilocus aetiology involving triplicated α-globin loci. Br J Haematol 1994; 86:372-6.
86. Sarakul O, Vattanaviboon P, Wilairat P, Fucharoen S, Abe Y, Muta K. Inhibition of α-globin gene expression by RNAi. Biochem Biophys Res Comm 2008;369:935-8.
87. Xie SY, Ren ZR, Zhang JZ, Guo XB, Wang QX, Wang S, et al. Restoration of the balanced α/β-globin gene expression in β654-thalassemia mice using combined RNAi and antisense RNA approach. Hum Mol Genet 2007;16:2616-25.
88. Voon HP, Wardan H, Vadolas J. siRNA-mediated reduction of {α}-globin results in phenotypic improvements in {β}-thalassemic cells. Haematologica 2008;93:1238-42.
89. Steensma DP, Gibbons RJ, Higgs DR. Acquired α-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies. Blood 2005;105:443-52.
90. Gibbons RJ, Picketts DJ, Villard L, Higgs DR. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with α-thalassemia (ATR-X syndrome). Cell 1995;80:837-45.